Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort ascending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort ascending Functional Area Date Posted
(高级)地区经理 Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Urumqi (Xinjiang Province) China International Innovative Medicines Sales Oct 21, 2024
县域主任(主管) Pingdingshan (Henan Province) China International Innovative Medicines Sales Oct 21, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Jinhua (Zhejiang Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Tianjin (Tianjin) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Zhenjiang (Jiangsu Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Qiqihar (Heilongjiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Shijiazhuang (Hebei Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Qingdao (Shandong Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Yantai (Shandong Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 27, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 01, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Contracts Manager - LDC Solutions Design Manager - Barcelona Gran Vía Spain Operations CTS Marketing Sep 03, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Jul 22, 2024
REFS Key Account & Business Relationship Manager Basel (City) Switzerland Operations CTS Facilities & Administration Aug 30, 2024
Senior Specialist IT (Service Operations Expert) Prague Czech Republic Operations CTS Technology Transformation Sep 03, 2024
Sr. Automation Engineer Carlsbad USA Operations CTS Research & Development Aug 02, 2024
Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) Hyderabad (Office) India Operations CTS Technology Transformation Aug 05, 2024
RWE Scientific data analyst II Hyderabad (Office) India Operations CTS Data and Digital Aug 06, 2024
Senior RWE Scientific Data Analyst Hyderabad (Office) India Operations CTS Data and Digital Aug 06, 2024
Senior Platform Linux Engineer / DevOps Prague Czech Republic Operations CTS Technology Transformation Aug 06, 2024
BS/Sol.Delivery-Data Engineer Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
ITOT Specialist Indianapolis USA Operations CTS Technical Operations Aug 08, 2024
Associate Director, M365 Platform Design & Delivery Hyderabad (Office) India Operations CTS Technology Transformation Aug 12, 2024
Real World Evidence Research Analyst Dublin (Novartis Corporate Center (NOCC)) Ireland Operations CTS Market Access Aug 12, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
Assoc. Director, Technical Solution Delivery, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Global Clinical Supply Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Principal Scientific Writer Hyderabad (Office) India Operations CTS Research & Development Sep 03, 2024
Manager - Advanced Analytics Hyderabad (Office) India Operations CTS Data and Digital May 17, 2024
Microsoft 365 Solution Architect Prague Czech Republic Operations CTS Technology Transformation May 16, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources May 19, 2024
Analyst – Patient Oriented Programs Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Associate Director Data Science Hyderabad (Office) India Operations CTS Data and Digital May 20, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation May 21, 2024
Senior Analyst - Data & Products Hyderabad (Office) India Operations CTS Marketing May 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 42
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic